Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future
- PMID: 27547134
- PMCID: PMC4979382
- DOI: 10.14503/THIJ-16-5785
Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future
Keywords: Administration, oral; anti-arrhythmia agents/therapeutic use; anticoagulants/administration & dosage/adverse effects/therapeutic use; atrial fibrillation/complications/drug therapy/epidemiology; attitude of health personnel; clinical trials as topic; practice guidelines as topic/standards; risk assessment/standards; risk factors; stroke/etiology/prevention & control.
References
-
- Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104(11):1534–9. - PubMed
-
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–8. - PubMed
-
- Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, Carolei A. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005;36(6):1115–9. - PubMed
-
- Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857–67. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous